FOXO3 and triple-negative breast carcinoma: –Park S-H, Chung YM, Ma J, Yang Q, Berek JS, Hu MC-T. Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo. Oncotarget. 2016 Jul 5;7(27):42110–25.